Use of celecoxib and all nsNSAIDs studied was associated with a greater risk of upper GI toxicity as compared with nonuse. The adjusted risk was 1.52 times higher for celecoxib and 2.56 times higher for oral nsNSAIDs. The ORs were above 2 for oral piroxicam, diclofenac, ketorolac, ketoprofen, acemetacin, and naproxen and were around 1.5 … Continue reading Use of celecoxib and all nsNSAIDs studied was associated with a greater risk of upper GI toxicity as compared with nonuse.
Gluten causes gastrointestinal symptoms in subjects without celiac disease: !!!Amplify’d from http://www.medscape.comGluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am J Gastroenterol. 2011; 106(3):508-14; quiz 515 (ISSN: 1572-0241)Biesiekierski JR; Newnham ED; Irving PM; Barrett JS; Haines M; Doecke JD; Shepherd SJ; Muir JG; Gibson PRMonash University Department of Medicine and Gastroenterology, Box Hill Hospital, Box Hill, Victoria, Australia.OBJECTIVES: Despite … Continue reading “I told you…” Dr. Rutledge
Fructose intake has increased considerably in the United States, primarily as a result of increased consumption of high-fructose corn syrup, fruits and juices, and crystalline fructose. Fructose may result in gastrointestinal distress in normal people.Amplify’d from http://www.ncbi.nlm.nih.govJ Am Diet Assoc. 2005 Oct;105(10):1559-66.Fructose intake at current levels in the United States may cause gastrointestinal distress in … Continue reading Fructose may result in gastrointestinal distress in normal people.
Gastric Bypass (MGB) Successfully Treats Type II DiabetesAmplify’d from clos.netGastric Bypass Surgery Cures Diabetes French researchers find diabetes disease quelled even if patient isn't obese Curr Opin Endocrinol Diabetes Obes. 2008 Apr;15(2):153-8. Links Gastrointestinal surgery as treatment for type 2 diabetes. Moo TA, Rubino F. Weill Cornell Medical College of Cornell University-New York … Continue reading Gastric Bypass (MGB) Successfully Treats Type II Diabetes